Cargando…

Evaluating dengue burden in Africa in passive fever surveillance and seroprevalence studies: protocol of field studies of the Dengue Vaccine Initiative

INTRODUCTION: Dengue is an important and well-documented public health problem in the Asia-Pacific and Latin American regions. However, in Africa, information on disease burden is limited to case reports and reports of sporadic outbreaks, thus hindering the implementation of public health actions fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Jacqueline Kyungah, Carabali, Mabel, Lee, Jung-Seok, Lee, Kang-Sung, Namkung, Suk, Lim, Sl-Ki, Ridde, Valéry, Fernandes, Jose, Lell, Bertrand, Matendechero, Sultani Hadley, Esen, Meral, Andia, Esther, Oyembo, Noah, Barro, Ahmed, Bonnet, Emmanuel, Njenga, Sammy M, Agnandji, Selidji Todagbe, Yaro, Seydou, Alexander, Neal, Yoon, In-Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780679/
https://www.ncbi.nlm.nih.gov/pubmed/29358421
http://dx.doi.org/10.1136/bmjopen-2017-017673
_version_ 1783294784516915200
author Lim, Jacqueline Kyungah
Carabali, Mabel
Lee, Jung-Seok
Lee, Kang-Sung
Namkung, Suk
Lim, Sl-Ki
Ridde, Valéry
Fernandes, Jose
Lell, Bertrand
Matendechero, Sultani Hadley
Esen, Meral
Andia, Esther
Oyembo, Noah
Barro, Ahmed
Bonnet, Emmanuel
Njenga, Sammy M
Agnandji, Selidji Todagbe
Yaro, Seydou
Alexander, Neal
Yoon, In-Kyu
author_facet Lim, Jacqueline Kyungah
Carabali, Mabel
Lee, Jung-Seok
Lee, Kang-Sung
Namkung, Suk
Lim, Sl-Ki
Ridde, Valéry
Fernandes, Jose
Lell, Bertrand
Matendechero, Sultani Hadley
Esen, Meral
Andia, Esther
Oyembo, Noah
Barro, Ahmed
Bonnet, Emmanuel
Njenga, Sammy M
Agnandji, Selidji Todagbe
Yaro, Seydou
Alexander, Neal
Yoon, In-Kyu
author_sort Lim, Jacqueline Kyungah
collection PubMed
description INTRODUCTION: Dengue is an important and well-documented public health problem in the Asia-Pacific and Latin American regions. However, in Africa, information on disease burden is limited to case reports and reports of sporadic outbreaks, thus hindering the implementation of public health actions for disease control. To gather evidence on the undocumented burden of dengue in Africa, epidemiological studies with standardised methods were launched in three locations in Africa. METHODS AND ANALYSIS: In 2014–2017, the Dengue Vaccine Initiative initiated field studies at three sites in Ouagadougou, Burkina Faso; Lambaréné, Gabon and Mombasa, Kenya to obtain comparable incidence data on dengue and assess its burden through standardised hospital-based surveillance and community-based serological methods. Multidisciplinary measurements of the burden of dengue were obtained through field studies that included passive facility-based fever surveillance, cost-of-illness surveys, serological surveys and healthcare utilisation surveys. All three sites conducted case detection using standardised procedures with uniform laboratory assays to diagnose dengue. Healthcare utilisation surveys were conducted to adjust population denominators in incidence calculations for differing healthcare seeking patterns. The fever surveillance data will allow calculation of age-specific incidence rates and comparison of symptomatic presentation between patients with dengue and non-dengue using multivariable logistic regression. Serological surveys assessed changes in immune status of cohorts of approximately 3000 randomly selected residents at each site at 6-month intervals. The age-stratified serosurvey data will allow calculation of seroprevalence and force of infection of dengue. Cost-of-illness evaluations were conducted among patients with acute dengue by Rapid Diagnostic Test. ETHICS AND DISSEMINATION: By standardising methods to evaluate dengue burden across several sites in Africa, these studies will generate evidence for dengue burden in Africa and data will be disseminated as publication in peer-review journals in 2018.
format Online
Article
Text
id pubmed-5780679
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-57806792018-01-31 Evaluating dengue burden in Africa in passive fever surveillance and seroprevalence studies: protocol of field studies of the Dengue Vaccine Initiative Lim, Jacqueline Kyungah Carabali, Mabel Lee, Jung-Seok Lee, Kang-Sung Namkung, Suk Lim, Sl-Ki Ridde, Valéry Fernandes, Jose Lell, Bertrand Matendechero, Sultani Hadley Esen, Meral Andia, Esther Oyembo, Noah Barro, Ahmed Bonnet, Emmanuel Njenga, Sammy M Agnandji, Selidji Todagbe Yaro, Seydou Alexander, Neal Yoon, In-Kyu BMJ Open Infectious Diseases INTRODUCTION: Dengue is an important and well-documented public health problem in the Asia-Pacific and Latin American regions. However, in Africa, information on disease burden is limited to case reports and reports of sporadic outbreaks, thus hindering the implementation of public health actions for disease control. To gather evidence on the undocumented burden of dengue in Africa, epidemiological studies with standardised methods were launched in three locations in Africa. METHODS AND ANALYSIS: In 2014–2017, the Dengue Vaccine Initiative initiated field studies at three sites in Ouagadougou, Burkina Faso; Lambaréné, Gabon and Mombasa, Kenya to obtain comparable incidence data on dengue and assess its burden through standardised hospital-based surveillance and community-based serological methods. Multidisciplinary measurements of the burden of dengue were obtained through field studies that included passive facility-based fever surveillance, cost-of-illness surveys, serological surveys and healthcare utilisation surveys. All three sites conducted case detection using standardised procedures with uniform laboratory assays to diagnose dengue. Healthcare utilisation surveys were conducted to adjust population denominators in incidence calculations for differing healthcare seeking patterns. The fever surveillance data will allow calculation of age-specific incidence rates and comparison of symptomatic presentation between patients with dengue and non-dengue using multivariable logistic regression. Serological surveys assessed changes in immune status of cohorts of approximately 3000 randomly selected residents at each site at 6-month intervals. The age-stratified serosurvey data will allow calculation of seroprevalence and force of infection of dengue. Cost-of-illness evaluations were conducted among patients with acute dengue by Rapid Diagnostic Test. ETHICS AND DISSEMINATION: By standardising methods to evaluate dengue burden across several sites in Africa, these studies will generate evidence for dengue burden in Africa and data will be disseminated as publication in peer-review journals in 2018. BMJ Publishing Group 2018-01-21 /pmc/articles/PMC5780679/ /pubmed/29358421 http://dx.doi.org/10.1136/bmjopen-2017-017673 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
spellingShingle Infectious Diseases
Lim, Jacqueline Kyungah
Carabali, Mabel
Lee, Jung-Seok
Lee, Kang-Sung
Namkung, Suk
Lim, Sl-Ki
Ridde, Valéry
Fernandes, Jose
Lell, Bertrand
Matendechero, Sultani Hadley
Esen, Meral
Andia, Esther
Oyembo, Noah
Barro, Ahmed
Bonnet, Emmanuel
Njenga, Sammy M
Agnandji, Selidji Todagbe
Yaro, Seydou
Alexander, Neal
Yoon, In-Kyu
Evaluating dengue burden in Africa in passive fever surveillance and seroprevalence studies: protocol of field studies of the Dengue Vaccine Initiative
title Evaluating dengue burden in Africa in passive fever surveillance and seroprevalence studies: protocol of field studies of the Dengue Vaccine Initiative
title_full Evaluating dengue burden in Africa in passive fever surveillance and seroprevalence studies: protocol of field studies of the Dengue Vaccine Initiative
title_fullStr Evaluating dengue burden in Africa in passive fever surveillance and seroprevalence studies: protocol of field studies of the Dengue Vaccine Initiative
title_full_unstemmed Evaluating dengue burden in Africa in passive fever surveillance and seroprevalence studies: protocol of field studies of the Dengue Vaccine Initiative
title_short Evaluating dengue burden in Africa in passive fever surveillance and seroprevalence studies: protocol of field studies of the Dengue Vaccine Initiative
title_sort evaluating dengue burden in africa in passive fever surveillance and seroprevalence studies: protocol of field studies of the dengue vaccine initiative
topic Infectious Diseases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780679/
https://www.ncbi.nlm.nih.gov/pubmed/29358421
http://dx.doi.org/10.1136/bmjopen-2017-017673
work_keys_str_mv AT limjacquelinekyungah evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative
AT carabalimabel evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative
AT leejungseok evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative
AT leekangsung evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative
AT namkungsuk evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative
AT limslki evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative
AT riddevalery evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative
AT fernandesjose evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative
AT lellbertrand evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative
AT matendecherosultanihadley evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative
AT esenmeral evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative
AT andiaesther evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative
AT oyembonoah evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative
AT barroahmed evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative
AT bonnetemmanuel evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative
AT njengasammym evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative
AT agnandjiselidjitodagbe evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative
AT yaroseydou evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative
AT alexanderneal evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative
AT yooninkyu evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative